Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Intrinsic Value
Beijing Tiantan Biological Products Corp. Ltd. engages in the research and development, production and sale of biological products. [ Read More ]
The intrinsic value of one Beijing Tiantan Biological Products Corp Ltd stock under the Base Case scenario is 30.44 CNY. Compared to the current market price of 30.4 CNY, Beijing Tiantan Biological Products Corp Ltd is Fairly Valued.
Valuation Backtest
Beijing Tiantan Biological Products Corp Ltd
Run backtest to discover the historical profit from buying and selling Beijing Tiantan Biological Products Corp Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Beijing Tiantan Biological Products Corp Ltd
| Current Assets | 7.6B |
| Cash & Short-Term Investments | 2.8B |
| Receivables | 133.2m |
| Other Current Assets | 4.6B |
| Non-Current Assets | 6.6B |
| Long-Term Investments | 214.8m |
| PP&E | 5B |
| Intangibles | 1.2B |
| Other Non-Current Assets | 165.9m |
| Current Liabilities | 1.3B |
| Accounts Payable | 74.4m |
| Accrued Liabilities | 98.1m |
| Short-Term Debt | 119.1m |
| Other Current Liabilities | 988m |
| Non-Current Liabilities | 3.1B |
| Long-Term Debt | 24.4m |
| Other Non-Current Liabilities | 3.1B |
Earnings Waterfall
Beijing Tiantan Biological Products Corp Ltd
|
Revenue
|
5.2B
CNY
|
|
Cost of Revenue
|
-2.6B
CNY
|
|
Gross Profit
|
2.6B
CNY
|
|
Operating Expenses
|
-911.6m
CNY
|
|
Operating Income
|
1.7B
CNY
|
|
Other Expenses
|
-606.3m
CNY
|
|
Net Income
|
1.1B
CNY
|
Free Cash Flow Analysis
Beijing Tiantan Biological Products Corp Ltd
Profitability Score
Profitability Due Diligence
Beijing Tiantan Biological Products Corp Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Beijing Tiantan Biological Products Corp Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Beijing Tiantan Biological Products Corp Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Score
Beijing Tiantan Biological Products Corp Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Beijing Tiantan Biological Products Corp Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Tiantan Biological Products Corp Ltd is 33.51 CNY with a low forecast of 32.03 CNY and a high forecast of 35.7 CNY.
Shareholder Return
Price
Beijing Tiantan Biological Products Corp Ltd
| Average Annual Return | 21.28% |
| Standard Deviation of Annual Returns | 45.13% |
| Max Drawdown | -63% |
| Market Capitalization | 50.1B CNY |
| Shares Outstanding | 1 647 809 538 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Beijing Tiantan Biological Products Corp. Ltd. engages in the research and development, production and sale of biological products. The company is headquartered in Beijing, Beijing and currently employs 3,933 full-time employees. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The firm mainly distributes its products within domestic markets and to Hong Kong markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Beijing Tiantan Biological Products Corp Ltd stock under the Base Case scenario is 30.44 CNY.
Compared to the current market price of 30.4 CNY, Beijing Tiantan Biological Products Corp Ltd is Fairly Valued.
You don't have any saved screeners yet
